Loads of cash and heaps of potential
This AIM listed connected healthcare group has delivered excellent results and the growing focus on data analytics in the life sciences sector could bring big rewards. In the meantime, the rating looks modest for such reliability of earnings and strong cash flow, while a growing dividend supports the patient…in more ways than one!
EMIS Group (AIM: EMIS), the provider of connected healthcare software and services, announced excellent results for the year ended 31 December 2021. EMIS Group’s solutions are widely used across every major UK healthcare setting, with the business operating across two core business segments: EMIS Health and EMIS Enterprise. EMIS Health is a supplier of integrated care technology to the NHS, including primary, community, acute and social care. EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services, data and analytics, and research and life sciences. Covid-19 accolades…